SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-034417
Filing Date
2020-11-02
Accepted
2020-11-02 09:15:19
Documents
4
Effectiveness Date
2020-11-02

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea129224-defa14a_ziopharm.htm DEFA14A 83082
2 GRAPHIC image_001.jpg GRAPHIC 11254
3 GRAPHIC image_002.jpg GRAPHIC 11679
4 GRAPHIC image_003.jpg GRAPHIC 4040
  Complete submission text file 0001213900-20-034417.txt   116381
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33038 | Film No.: 201279148
SIC: 2834 Pharmaceutical Preparations